Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Flaherty

Showing results (181-190 of 580) with videos related to

Pageof 58
Sort By:
Cancer Chemotherapy and Pharmacology|May 8, 2004
A phase I, dose escalation trial of ZD0473, a novel platinum analogue, in combination with gemcitabineKeith T Flaherty, James P Stevenson, Maryann Redlinger, et al.
Chest|September 22, 1998
African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung diseaseE L Greidinger, K T Flaherty, B White, et al.
Expert Review of Vaccines|June 14, 2026
Barriers to dengue vaccine uptake in international travelers: a mixed-methods studyRachata Charoenwisedsil, Saranath Lawpoolsri, Pinyo Rattanaumpawan, et al.
The Journal of Investigative Dermatology|August 25, 2015
BRAF Inhibition Generates a Host-Tumor Niche that Mediates Therapeutic EscapeInna V Fedorenko, Jennifer A Wargo, Keith T Flaherty, et al.
Circulation|January 1, 1975
Intravenous nitroglycerin in acute myocardial infarctionJ T Flaherty, P R Reid, D T Kelly, et al.
Recent Advances in Studies on Cardiac Structure and Metabolism|January 1, 1975
Mass spectrometry for the measurement of intramyocardial gas tensions: methodology and application to the study of myocardial ischemiaS F Khuri, J O'Riordan, J T Flaherty, et al.
Acta Crystallographica. Section E, Crystallographic Communications|May 3, 2021
Crystal structure of <i>tert</i>-butyl 4-[4-(4-fluoro-phen-yl)-2-methyl-but-3-yn-2-yl]piperazine-1-carboxyl-ateAshwini Gumireddy, Kevin DeBoyace, Alexander Rupprecht, et al.
Molecular Cancer Therapeutics|May 30, 2006
Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastasesKeiran S M Smalley, Nikolas K Haass, Patricia A Brafford, et al.
Cancer Chemotherapy and Pharmacology|February 26, 2011
Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction studyKeith T Flaherty, Chetan Lathia, Reginald F Frye, et al.
Travel Medicine and Infectious Disease|May 19, 2026
Incomplete rabies post-exposure prophylaxis in international travelers: an analysis of incidence and risk factorsTanatorn Soravipukuntorn, Punyisa Asawapaithulsert, Panita Looareesuwan, et al.
Pageof 58

Showing results (181-190 of 580) with videos related to

Sort By:
Pageof 58
Cancer Chemotherapy and Pharmacology|May 8, 2004
A phase I, dose escalation trial of ZD0473, a novel platinum analogue, in combination with gemcitabineKeith T Flaherty, James P Stevenson, Maryann Redlinger, et al.
Chest|September 22, 1998
African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung diseaseE L Greidinger, K T Flaherty, B White, et al.
Expert Review of Vaccines|June 14, 2026
Barriers to dengue vaccine uptake in international travelers: a mixed-methods studyRachata Charoenwisedsil, Saranath Lawpoolsri, Pinyo Rattanaumpawan, et al.
The Journal of Investigative Dermatology|August 25, 2015
BRAF Inhibition Generates a Host-Tumor Niche that Mediates Therapeutic EscapeInna V Fedorenko, Jennifer A Wargo, Keith T Flaherty, et al.
Circulation|January 1, 1975
Intravenous nitroglycerin in acute myocardial infarctionJ T Flaherty, P R Reid, D T Kelly, et al.
Recent Advances in Studies on Cardiac Structure and Metabolism|January 1, 1975
Mass spectrometry for the measurement of intramyocardial gas tensions: methodology and application to the study of myocardial ischemiaS F Khuri, J O'Riordan, J T Flaherty, et al.
Acta Crystallographica. Section E, Crystallographic Communications|May 3, 2021
Crystal structure of <i>tert</i>-butyl 4-[4-(4-fluoro-phen-yl)-2-methyl-but-3-yn-2-yl]piperazine-1-carboxyl-ateAshwini Gumireddy, Kevin DeBoyace, Alexander Rupprecht, et al.
Molecular Cancer Therapeutics|May 30, 2006
Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastasesKeiran S M Smalley, Nikolas K Haass, Patricia A Brafford, et al.
Cancer Chemotherapy and Pharmacology|February 26, 2011
Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction studyKeith T Flaherty, Chetan Lathia, Reginald F Frye, et al.
Travel Medicine and Infectious Disease|May 19, 2026
Incomplete rabies post-exposure prophylaxis in international travelers: an analysis of incidence and risk factorsTanatorn Soravipukuntorn, Punyisa Asawapaithulsert, Panita Looareesuwan, et al.
Pageof 58